Broadcast date: 28 Mar 2013
Time: 16.00-17.00 PM CET
Come and join our CEO, Attila Berces in a presentation and demo of how Omixon Target HLA is used in the analysis of targeted NGS data.
Register today!
Write an email to hajnalka.hejja@omixon.com. Continue reading <span class="meta-nav">→</span>
We are happy to tell you that we are attending the BioIT World conference in Boston, 9-11 April. Omixon will be exhibiting at booth No. 337. Continue reading <span class="meta-nav">→</span>
Our CTO, Tim Hague, just informed us about the incredibly positive feedback he has recently received about our Omixon Target HLA software solution. We also restructured its page in order to make the core messages even more clear.
Omixon Target HLA offers the highest possible HLA typing precision. There is no need to be an expert in NGS analysis and to spend hours editing the sequence.
Some of the feedback he got during a demonstration of Omixon Target HLA Typing:
“It is a quantum leap over anything we have seen.”
About the approval process: “This is a nice feature, especially in a clinical setting.”
”You should see my face (client said to Tim, who was on the phone). I am smiling. I am like a kid at Christmas.”
We are proud to announce that the submissions for an oral and two poster presentations of our CEO, Attila Bérces, were accepted for the upcoming 27th annual EFI European Immunogenetics and Histocompatibility Conference in Maastricht, The Netherlands.
After several conferences this year, there is a new chance for showing what we do with Omixon Target and how it can be useful in cancer research, HLA typing and many other fields of medicine and science.
We plan to publish updates during the conference as well!
We are glad to announce that Omixon is presenting and exhibiting at East-West Immunogenetics Conference in Prague, Czech Republic, 6-8 March. The main topics are immunogenetics of organ and stem cell transplantation, role of the HLA laboratories in the diagnosis of antibody-mediated rejection, disease association studies and stem cell donor registries in Central and Eastern Europe.
Our CEO, Attila Bérces, is giving a paper with the title of High-resolution HLA Typing of HapMap NGS Samples From 1000 Genomes Paired Illumina Reads.
Contact me, if you would like to schedule a meeting during this event: hajnalka.hejja@omixon.com
